Renal cell carcinoma and Dry eyes

Summary:

Dry eyes is found among people with Renal cell carcinoma, especially for people who are female, 60+ old.

The study analyzes which people have Dry eyes with Renal cell carcinoma. It is created by eHealthMe based on reports of 91 people who have Renal cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 789 drugs and 1,335 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

What is Dry eyes?

Dry eyes (lack of adequate tears) is found to be associated with 1,579 drugs and 2,052 conditions by eHealthMe. Check the latest studies of Dry eyes.



On Jul, 28, 2026

91 people who have Renal Cell Carcinoma and Dry Eyes are studied.

Would you have Dry eyes when you have Renal cell carcinoma?

Gender of people who have Renal Cell Carcinoma and experienced Dry Eyes *:

  • female: 51.16 %
  • male: 48.84 %

Age of people who have Renal Cell Carcinoma and experienced Dry Eyes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.33 %
  • 50-59: 31.67 %
  • 60+: 65.0 %

Common co-existing conditions for these people *:

  1. Constipation: 4 people, 4.40%
  2. Neoplasm Malignant (cancer tumour): 4 people, 4.40%
  3. Metastases To Lung (cancer spreads to lung): 4 people, 4.40%
  4. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 3 people, 3.30%
  5. Metastases To Lymph Nodes (cancer spreads to lymph node): 3 people, 3.30%
  6. Anaemia (lack of blood): 3 people, 3.30%
  7. Dyslipidaemia (abnormal amount of lipids): 3 people, 3.30%
  8. Folate Deficiency (lack of folic acid): 3 people, 3.30%
  9. Hyperthyroidism (over activity of the thyroid gland): 3 people, 3.30%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 3.30%

Common drugs taken by these people *:

  1. Cabometyx: 36 people, 39.56%
  2. Sutent: 20 people, 21.98%
  3. Opdivo: 18 people, 19.78%
  4. Afinitor: 9 people, 9.89%
  5. Eliquis: 9 people, 9.89%
  6. Tylenol: 7 people, 7.69%
  7. Synthroid: 7 people, 7.69%
  8. Oxycodone: 7 people, 7.69%
  9. Vitamin D3: 7 people, 7.69%
  10. Vitamin C: 6 people, 6.59%

Common symptoms for these people *:

  1. Diarrhea: 41 people, 45.05%
  2. Fatigue (feeling of tiredness): 40 people, 43.96%
  3. Nausea (feeling of having an urge to vomit): 33 people, 36.26%
  4. Dry Mouth: 27 people, 29.67%
  5. Nausea And Vomiting: 23 people, 25.27%
  6. High Blood Pressure: 22 people, 24.18%
  7. Rhinorrhea (watery mucus discharge from the nose): 19 people, 20.88%
  8. Weight Decreased: 19 people, 20.88%
  9. Weakness: 19 people, 20.88%
  10. Dizziness: 18 people, 19.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dry eyes?

- Check whether Dry eyes is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Dry eyes:

All the conditions that are associated with Dry eyes:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Dry eyes and Renal cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: